Evidence map›Paper›PMID 24201760›Full record

Trial reportJAMA ophthalmology2014

Randomized crossover clinical trial of real and sham peripheral prism glasses for hemianopia.

Alex R Bowers, Karen Keeney, Eli Peli

Registry-linked trialOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA ophthalmology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00494676 (Community-based Multi-center Randomized Control Trial of Peripheral Prism Glasses for Hemianopia), which is not on this map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00494676 nacompletednot on this map

Community-based Multi-center Randomized Control Trial of Peripheral Prism Glasses for Hemianopia

TypeinterventionalSponsorAlexandra BowersRan2007 to 2010Enrolled73ConditionsHomonymous HemianopiaArmsHigh power (57 prism diopter) peripheral prism glasses, Low power sham peripheral prism glasses
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Interventions for visual field defects in people with stroke.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Pilot study of a pedestrian collision detection test for a multisite trial of field expansion devices for hemianopia.Optometry and vision science : official publication of the American Academy of Optometry · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Effects of Perceptual-motor Training on Collision Judgments with Peripheral Prism Expanded Vision.Optometry and vision science : official publication of the American Academy of Optometry · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. 2017 Charles F. Prentice Award Lecture: Peripheral Prisms for Visual Field Expansion: A Translational Journey.Optometry and vision science : official publication of the American Academy of Optometry · 2020
    Article
  18. Article
  19. Update on the Clinical Approach to Spatial Neglect.Current neurology and neuroscience reports · 2019
    Review
  20. Field Expansion for Acquired Monocular Vision Using a Multiplexing Prism.Optometry and vision science : official publication of the American Academy of Optometry · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Alex R BowersSchepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
Karen KeeneyChadwick Optical, Inc, Souderton, Philadelphia.
Eli PeliSchepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
Chadwick Optical (United States) · USHarvard University · USSmith-Kettlewell Eye Research Institute · US

Funding

ENGINEERING APPROACHES TO LOW VISION REHABILITATIONR24EY012890 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI PELI, ELI · 2000 to 2005
$7.2M
ENGINEERING APPROACHES TO LOW VISION REHABILITATIONR01EY012890 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI PELI, ELI · 2006 to 2010
$7.0M
Field Expansion Prism Glasses for Homonymous HemianopsiaR44EY014723 · NEI · CHADWICK OPTICAL, INC. · PI KEENEY, KAREN L · 2006 to 2007
$749k
Field Expansion Prism Glasses for Homonymous HemianopiaR43EY014723 · NEI · CHADWICK OPTICAL, INC. · PI KEENEY, KAREN L · 2003 to 2004
$527k
NEI NIH HHS EY014723NEI NIH HHS EY12890NEI NIH HHS R01 EY012890NEI NIH HHS R24 EY012890NEI NIH HHS R43 EY014723NEI NIH HHS R44 EY014723
6 · The paper itself

Abstract

importanceThere is a major lack of randomized controlled clinical trials evaluating the efficacy of prismatic treatments for hemianopia. Evidence for their effectiveness is mostly based on anecdotal case reports and open-label evaluations without a control condition.

objectiveTo evaluate the efficacy of real relative to sham peripheral prism glasses for patients with complete homonymous hemianopia. DESIGN, SETTING, AND

participantsDouble-masked, randomized crossover trial at 13 study sites, including the Peli laboratory at Schepens Eye Research Institute, 11 vision rehabilitation clinics in the United States, and 1 in the United Kingdom. Patients were 18 years or older with complete homonymous hemianopia for at least 3 months and without visual neglect or significant cognitive decline.

interventionPatients were allocated by minimization into 2 groups. One group received real (57-prism diopter) oblique and sham (<5-prism diopter) horizontal prisms; the other received real horizontal and sham oblique, in counterbalanced order. Each crossover period was 4 weeks. MAIN OUTCOMES AND MEASURES: The primary outcome was the overall difference, across the 2 periods of the crossover, between the proportion of participants who wanted to continue with (said yes to) real prisms and the proportion who said yes to sham prisms. The secondary outcome was the difference in perceived mobility improvement between real and sham prisms.

resultsOf 73 patients randomized, 61 completed the crossover. A significantly higher proportion said yes to real than sham prisms (64% vs 36%; odds ratio, 5.3; 95% CI, 1.8-21.0). Participants who continued wear after 6 months reported greater improvement in mobility with real than sham prisms at crossover end (P = .002); participants who discontinued wear reported no difference. CONCLUSIONS AND RELEVANCE: Real peripheral prism glasses were more helpful for obstacle avoidance when walking than sham glasses, with no differences between the horizontal and oblique designs. Peripheral prism glasses provide a simple and inexpensive mobility rehabilitation intervention for hemianopia.

trial registrationclinicaltrials.gov Identifier: NCT00494676.

Indexed as

EyeglassesActivities of Daily LivingAdolescentAdultAgedAged, 80 and overCross-Over StudiesDouble-Blind MethodFemaleHemianopsiaHumansMaleMiddle AgedPatient SatisfactionPlacebosProsthesis DesignPlacebos

Identifiers

PMID24201760
PMCPMC3945165
OpenAlexW2147470091

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.